Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: Comparison with TI-201 imaging

Junichi Taki, Takahiro Higuchi, Hisashi Sumiya, Hiroyuki Tsuchiya, Hiroshi Minato, Katsuro Tomita, Norihisa Tonami

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The aim of this study was to assess the predictive power of 99mTc-MIBI scintigraphy performed in the middle of chemotherapy, for the final tumor response to chemotherapy, and compare it to that of 201T1 in malignant bone and soft tissue tumors (MBST). Sixty-eight patients with MBST underwent 99mTc-MIBI and 201T1 scintigraphies at 15 min after tracer injection before the first, and after the third, chemotherapy cycles. After five cycles of chemotherapy and tumor resection, therapeutic effect was assessed by histopathology. Less than 90% and ≥90% necrosis were judged as poor and good response to chemotherapy, respectively. Tracers uptake ratios were calculated by dividing the lesion count density by that of the background. 99mTc-MIBI perfusion index was also calculated. The % reduction of the perfusion index (ΔPI) and uptake ratios (ΔUR) calculated by 100 ′ [(prechemotherapy value - postchemotherapy value)/prechemotherapy value] were compared with histologic response. The sensitivity, specificity, and accuracy for the prediction of effective chemotherapy in 99mTc-MIBI imaging were 80%, 95%, 88% in ΔUR, and 74%, 74%, 74% in ΔPI, respectively. The area under the receiver operator characteristic curve (Az of the 99mTc-MIBI-ΔUR (0.923) was significantly higher than that of API (0.809, p = 0.025) but only marginally higher than that of the 201T1-ΔUR (0.865, p = 0.079). Az in 201T1 (0.865) was not significantly different from that of ΔPI (0.809, p = 0.35). 99mTc-MIBI imaging performed in the middle of chemotherapy well predicts the final tumor response to chemotherapy in patients with malignant bone and soft tissue tumors.

Original languageEnglish
Pages (from-to)411-418
Number of pages8
JournalJournal of Orthopaedic Research
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 1 2008
Externally publishedYes

Fingerprint

Technetium Tc 99m Sestamibi
Bone and Bones
Drug Therapy
Neoplasms
Perfusion
Radionuclide Imaging
Therapeutic Uses
Necrosis
Sensitivity and Specificity
Injections

Keywords

  • Bone tumor
  • Preoperative chemotherapy
  • Soft tissue tumor
  • Tc-99m-MIBI
  • TI-201

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors : Comparison with TI-201 imaging. / Taki, Junichi; Higuchi, Takahiro; Sumiya, Hisashi; Tsuchiya, Hiroyuki; Minato, Hiroshi; Tomita, Katsuro; Tonami, Norihisa.

In: Journal of Orthopaedic Research, Vol. 26, No. 3, 01.03.2008, p. 411-418.

Research output: Contribution to journalArticle

@article{138be3c0cf0e4619a8b100397ebcd74b,
title = "Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: Comparison with TI-201 imaging",
abstract = "The aim of this study was to assess the predictive power of 99mTc-MIBI scintigraphy performed in the middle of chemotherapy, for the final tumor response to chemotherapy, and compare it to that of 201T1 in malignant bone and soft tissue tumors (MBST). Sixty-eight patients with MBST underwent 99mTc-MIBI and 201T1 scintigraphies at 15 min after tracer injection before the first, and after the third, chemotherapy cycles. After five cycles of chemotherapy and tumor resection, therapeutic effect was assessed by histopathology. Less than 90{\%} and ≥90{\%} necrosis were judged as poor and good response to chemotherapy, respectively. Tracers uptake ratios were calculated by dividing the lesion count density by that of the background. 99mTc-MIBI perfusion index was also calculated. The {\%} reduction of the perfusion index (ΔPI) and uptake ratios (ΔUR) calculated by 100 ′ [(prechemotherapy value - postchemotherapy value)/prechemotherapy value] were compared with histologic response. The sensitivity, specificity, and accuracy for the prediction of effective chemotherapy in 99mTc-MIBI imaging were 80{\%}, 95{\%}, 88{\%} in ΔUR, and 74{\%}, 74{\%}, 74{\%} in ΔPI, respectively. The area under the receiver operator characteristic curve (Az of the 99mTc-MIBI-ΔUR (0.923) was significantly higher than that of API (0.809, p = 0.025) but only marginally higher than that of the 201T1-ΔUR (0.865, p = 0.079). Az in 201T1 (0.865) was not significantly different from that of ΔPI (0.809, p = 0.35). 99mTc-MIBI imaging performed in the middle of chemotherapy well predicts the final tumor response to chemotherapy in patients with malignant bone and soft tissue tumors.",
keywords = "Bone tumor, Preoperative chemotherapy, Soft tissue tumor, Tc-99m-MIBI, TI-201",
author = "Junichi Taki and Takahiro Higuchi and Hisashi Sumiya and Hiroyuki Tsuchiya and Hiroshi Minato and Katsuro Tomita and Norihisa Tonami",
year = "2008",
month = "3",
day = "1",
doi = "10.1002/jor.20522",
language = "English",
volume = "26",
pages = "411--418",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors

T2 - Comparison with TI-201 imaging

AU - Taki, Junichi

AU - Higuchi, Takahiro

AU - Sumiya, Hisashi

AU - Tsuchiya, Hiroyuki

AU - Minato, Hiroshi

AU - Tomita, Katsuro

AU - Tonami, Norihisa

PY - 2008/3/1

Y1 - 2008/3/1

N2 - The aim of this study was to assess the predictive power of 99mTc-MIBI scintigraphy performed in the middle of chemotherapy, for the final tumor response to chemotherapy, and compare it to that of 201T1 in malignant bone and soft tissue tumors (MBST). Sixty-eight patients with MBST underwent 99mTc-MIBI and 201T1 scintigraphies at 15 min after tracer injection before the first, and after the third, chemotherapy cycles. After five cycles of chemotherapy and tumor resection, therapeutic effect was assessed by histopathology. Less than 90% and ≥90% necrosis were judged as poor and good response to chemotherapy, respectively. Tracers uptake ratios were calculated by dividing the lesion count density by that of the background. 99mTc-MIBI perfusion index was also calculated. The % reduction of the perfusion index (ΔPI) and uptake ratios (ΔUR) calculated by 100 ′ [(prechemotherapy value - postchemotherapy value)/prechemotherapy value] were compared with histologic response. The sensitivity, specificity, and accuracy for the prediction of effective chemotherapy in 99mTc-MIBI imaging were 80%, 95%, 88% in ΔUR, and 74%, 74%, 74% in ΔPI, respectively. The area under the receiver operator characteristic curve (Az of the 99mTc-MIBI-ΔUR (0.923) was significantly higher than that of API (0.809, p = 0.025) but only marginally higher than that of the 201T1-ΔUR (0.865, p = 0.079). Az in 201T1 (0.865) was not significantly different from that of ΔPI (0.809, p = 0.35). 99mTc-MIBI imaging performed in the middle of chemotherapy well predicts the final tumor response to chemotherapy in patients with malignant bone and soft tissue tumors.

AB - The aim of this study was to assess the predictive power of 99mTc-MIBI scintigraphy performed in the middle of chemotherapy, for the final tumor response to chemotherapy, and compare it to that of 201T1 in malignant bone and soft tissue tumors (MBST). Sixty-eight patients with MBST underwent 99mTc-MIBI and 201T1 scintigraphies at 15 min after tracer injection before the first, and after the third, chemotherapy cycles. After five cycles of chemotherapy and tumor resection, therapeutic effect was assessed by histopathology. Less than 90% and ≥90% necrosis were judged as poor and good response to chemotherapy, respectively. Tracers uptake ratios were calculated by dividing the lesion count density by that of the background. 99mTc-MIBI perfusion index was also calculated. The % reduction of the perfusion index (ΔPI) and uptake ratios (ΔUR) calculated by 100 ′ [(prechemotherapy value - postchemotherapy value)/prechemotherapy value] were compared with histologic response. The sensitivity, specificity, and accuracy for the prediction of effective chemotherapy in 99mTc-MIBI imaging were 80%, 95%, 88% in ΔUR, and 74%, 74%, 74% in ΔPI, respectively. The area under the receiver operator characteristic curve (Az of the 99mTc-MIBI-ΔUR (0.923) was significantly higher than that of API (0.809, p = 0.025) but only marginally higher than that of the 201T1-ΔUR (0.865, p = 0.079). Az in 201T1 (0.865) was not significantly different from that of ΔPI (0.809, p = 0.35). 99mTc-MIBI imaging performed in the middle of chemotherapy well predicts the final tumor response to chemotherapy in patients with malignant bone and soft tissue tumors.

KW - Bone tumor

KW - Preoperative chemotherapy

KW - Soft tissue tumor

KW - Tc-99m-MIBI

KW - TI-201

UR - http://www.scopus.com/inward/record.url?scp=40949158912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949158912&partnerID=8YFLogxK

U2 - 10.1002/jor.20522

DO - 10.1002/jor.20522

M3 - Article

C2 - 17960652

AN - SCOPUS:40949158912

VL - 26

SP - 411

EP - 418

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 3

ER -